Original article
Low dose thymoglobulin versus basiliximab in cytomegalovirus positive kidney transplant recipients: Effectiveness of preemptive cytomegalovirus modified strategy
Timoglobulina en dosis bajas vs. basiliximab en receptores de trasplante renal positivos para citomegalovirus: efectividad de una estrategia preventiva modificada
Camilo Monteroa,b,
, Nancy Yomayusaa,b,c, Rodolfo Torresa,b, Jorge Cortesd, Carlos Alvarezb,c, Juan Galloa, Guillermo Aldanaa, Andres Acevedoa,b, Maria Riose, Johana Echeverrie, Zuly Yepese, Adriana Silvaa, Diana Gayona, Jorge Pereza,b,c,e, Milciades Ibaneza,b
Corresponding author
a Renal Transplantation Group, Clinica Reina Sofia, University Clinic, Bogota, Colombia
b Translational Investigation Group, Sanitas University, Clinica Colsanitas, Bogota, Colombia
c Infectious Diseases Department, Clinica Colsanitas, Bogota, Colombia
d Facultad de Medicina, Universidad Nacional de Colombia
e Molecular Biology and Immunology Laboratory, Clinica Colsanitas, Bogota, Colombia
Read
1726
Timeswas read the article
709
Total PDF
1017
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 12 | 12 | 24 |
| 2024 April | 67 | 53 | 120 |
| 2024 March | 52 | 28 | 80 |
| 2024 February | 58 | 49 | 107 |
| 2024 January | 35 | 32 | 67 |
| 2023 December | 49 | 27 | 76 |
| 2023 November | 61 | 47 | 108 |
| 2023 October | 73 | 42 | 115 |
| 2023 September | 72 | 57 | 129 |
| 2023 August | 154 | 47 | 201 |
| 2023 July | 87 | 53 | 140 |
| 2023 June | 57 | 23 | 80 |
| 2023 May | 46 | 32 | 78 |
| 2023 April | 32 | 25 | 57 |
| 2023 March | 37 | 29 | 66 |
| 2023 February | 32 | 31 | 63 |
| 2023 January | 45 | 60 | 105 |
| 2022 December | 34 | 56 | 90 |
| 2022 November | 14 | 6 | 20 |
Show all
